Mirum Pharmaceuticals (MIRM) Other Accumulated Expenses (2021 - 2023)

Mirum Pharmaceuticals' Other Accumulated Expenses history runs 3 years deep, the most recent figure standing at $6.7 million for Q4 2023.

• In Q4 2023, Other Accumulated Expenses rose 173.45% year-over-year to $6.7 million; the TTM figure through Dec 2023 stood at $6.7 million (up 173.45% YoY), while the FY2023 annual figure was $6.7 million, up 173.45% from the prior year.
• Other Accumulated Expenses for Q4 2023 stood at $6.7 million, up from $4.4 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $6.7 million in Q4 2023, with the low at $345000.0 in Q4 2021.
• The 3-year median for Other Accumulated Expenses is $2.5 million (2022), against an average of $2.7 million.
• The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses soared 611.88% in 2022, then surged 66.21% in 2023.
• Mirum Pharmaceuticals' Other Accumulated Expenses stood at $345000.0 in 2021, then jumped by 611.88% to $2.5 million in 2022, then jumped by 173.45% to $6.7 million in 2023.
• Business Quant data shows MIRM's Other Accumulated Expenses at $6.7 million in Q4 2023, $4.4 million in Q3 2023, and $2.9 million in Q2 2023.